AI Radiology Tool Market Report 2026

The artificial intelligence (AI) radiology tool market size has grown rapidly in recent years. It will grow from $1.74 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increasing medical imaging volumes, rising shortage of radiologists, early adoption of computer-aided detection systems, expansion of digital radiology infrastructure, growing healthcare imaging demand.

The artificial intelligence (AI) radiology tool market size is expected to see rapid growth in the next few years. It will grow to $3.69 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing deployment of cloud-based radiology ai platforms, rising focus on precision diagnostics, expansion of ai in interventional radiology, growing investments in automated reporting systems, increasing regulatory approvals for ai imaging tools. Major trends in the forecast period include increasing adoption of AI-based image interpretation tools, rising integration of workflow automation in radiology, growing use of ai for early anomaly detection, expansion of AI-assisted diagnostic accuracy solutions, enhanced focus on reducing radiologist workload.

The growing emphasis on personalized medicine is expected to drive the expansion of the artificial intelligence (AI) radiology tool market in the coming years. Personalized medicine, also called precision medicine, is an innovative healthcare approach that customizes treatment and medical strategies based on the unique characteristics of each patient. This growing focus on personalized medicine is fueled by several key factors, including advancements in genomics and molecular biology. AI radiology tools support personalized medicine by delivering accurate diagnostics, predictive analytics, real-time monitoring of treatment responses, integration with genomic information, and enhanced patient stratification, facilitating individualized and effective healthcare interventions. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Consequently, the increasing adoption of personalized medicine is propelling the growth of the artificial intelligence (AI) radiology tool market.

Key players in the artificial intelligence (AI) radiology tool market are developing advanced solutions, such as AI platforms, to improve the diagnostic capabilities of radiologists. An advanced AI platform integrates sophisticated algorithms to analyze medical imaging data, providing radiologists with enhanced insights and supporting accurate detection and diagnosis of various medical conditions. For instance, in November 2023, Radiology Partners (RP), a US-based radiology practice company, introduced RPX AI, a cloud-based advanced AI platform designed for rapid deployment of AI medical imaging tools at scale using Amazon Web Services (AWS) HealthImaging. This platform aims to streamline the integration and implementation of medical imaging AI models, making them more accessible and efficient for hospitals and healthcare systems.

In April 2024, GE HealthCare, a US-based medical technology company, acquired MIM Software for an undisclosed sum. This acquisition enhances GE HealthCare's position in the medical imaging market by offering advanced AI-powered imaging analysis and workflow solutions, improving its capability to deliver precision care and optimize patient outcomes. MIM Software Inc. is a US-based software company that provides AI-driven medical imaging solutions for radiology and radiation oncology.

Major companies operating in the artificial intelligence (AI) radiology tool market are Google LLC, Microsoft Corporation, NVIDIA Corporation, Siemens Healthcare Private Limited, Koninklijke Philips N.V., GE HealthCare, Nuance Communications Inc., Aidoc Medical, Subtle Medical Inc., Enlitic Inc., Arterys Inc., Aidence.com, Oxipit.ai, Zebra Medical Vision.

North America was the largest region in the artificial intelligence (AI) radiology tool market in 2025. The regions covered in the artificial intelligence (AI) radiology tool market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) radiology tool market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the artificial intelligence radiology tool market by increasing costs of imported imaging hardware, GPUs, data servers, and advanced visualization equipment used alongside AI software. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported imaging systems, while Asia-Pacific faces higher costs in deploying advanced radiology infrastructure. These tariffs are increasing capital investment requirements and delaying technology upgrades. At the same time, they are supporting local assembly of imaging equipment, regional software development, and wider adoption of cloud-native AI radiology tools.

The artificial intelligence (AI) radiology tool market research report is one of a series of new reports that provides artificial intelligence (AI) radiology tool market statistics, including artificial intelligence (AI) radiology tool industry global market size, regional shares, competitors with a artificial intelligence (AI) radiology tool market share, detailed artificial intelligence (AI) radiology tool market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) radiology tool industry. This artificial intelligence (AI) radiology tool market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An artificial intelligence (AI) radiology tool is an advanced software application that employs machine learning algorithms and sophisticated data analysis methods to aid radiologists in interpreting and diagnosing medical imaging studies. These tools examine different medical images, including X-rays, CT scans, MRIs, and ultrasounds, to detect abnormalities, recognize patterns, and provide quantitative evaluations that may be difficult for human radiologists to identify quickly. The primary goal of AI radiology tools is to enhance the accuracy, efficiency, and speed of medical image interpretation, resulting in improved patient outcomes and reduced healthcare costs.

The main types of artificial intelligence (AI) radiology tools are diagnostic radiology and interventional radiology. Diagnostic radiology is a medical field that uses various imaging techniques to diagnose and monitor diseases and injuries within the body. Its applications span eye care, oncology, radiology, cardiovascular, pathology, and other areas, and it is utilized by clinics, hospitals, diagnostic centers, and various other end-users.

The artificial intelligence (AI) radiology tool market consists of revenues earned by entities by providing services such as, diagnostic imaging services, cloud-based solutions and data management, and workflow optimization and automation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) radiology tool market also includes sales of high-resolution imaging equipment, graphics processing units (GPUs), and medical image acquisition devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.